InvestorsHub Logo
Post# of 252190
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: biomaven0 post# 143774

Thursday, 06/14/2012 8:44:47 AM

Thursday, June 14, 2012 8:44:47 AM

Post# of 252190
Agree that long term Eylea/Fovista should work just as well but if Roche or Novartis buy Ophthotech they can coformulate Fovista&Lucentis and have a unique new product.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.